Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|August 15, 2013
Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cellsPhilipp Saiko, Geraldine Graser, Benedikt Giessrigl, et al.
International Journal of Oncology|September 3, 2009
In vitro anti-inflammatory and anticancer activities of extracts of Acalypha alopecuroidea (Euphorbiaceae)Sibylle Madlener, Jana Svacinová, Miloslav Kitner, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 1, 2015
Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosinePhilipp Saiko, Marie-Thérèse Steinmann, Heike Schuster, et al.
Investigational New Drugs|October 9, 2008
Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cellsAstrid Bernhaus, Maria Ozsvar-Kozma, Philipp Saiko, et al.
Nature Cell Biology|March 15, 2016
C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4Bruno Di Stefano, Samuel Collombet, Janus Schou Jakobsen, et al.
Journal of Hepatology|August 29, 2006
Deregulation of the activin/follistatin system in hepatocarcinogenesisMichael Grusch, Claudia Drucker, Barbara Peter-Vörösmarty, et al.
Cancer Letters|January 21, 2012
The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cellsAnnemarie Losert, Daniela Lötsch, Andreas Lackner, et al.
Nature Communications|June 22, 2021
Genomic imprinting in mouse blastocysts is predominantly associated with H3K27me3Laura Santini, Florian Halbritter, Fabian Titz-Teixeira, et al.
Pageof 5